₹0.36
(Market cap
₹8 Cr
Revenue (TTM)
₹6 Cr
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-1 Cr
-
ROE
-7.7 %
-
ROCE
-1.2 %
-
Industry P/E
39.9
-
EV/EBITDA
254.1
-
Debt to Equity
1.1
-
Book Value
₹--
-
EPS
₹-0.3
-
Face value
10
-
Shares outstanding
10,002,600
5 Years Aggregate
CFO
₹-10.98 Cr
EBITDA
₹5.74 Cr
Net Profit
₹-0.21 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Roselabs
| -13.1 | -2.8 | 43.9 | -37.4 | -- | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2015
|
2014
|
|---|---|---|
|
Roselabs
| -19.5 | -59.5 |
|
BSE Sensex
| -5.0 | 29.9 |
|
BSE Healthcare
| 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Roselabs
|
7.7 | 7.7 | 5.7 | -0.4 | -0.2 | -2.7 | -- | 0.8 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Roselabs
Other non-specialised wholesale trade n.e.c.
-
Incorporated
1995
-
Chairman
Pawan Kumar Agrawal
-
Managing Director
Pawan Kumar Agrawal
-
Headquarters
Ahmedabad, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Roselabs
What is the current share price of Roselabs Ltd Today?
The share price of Roselabs Ltd is ₹7.70 (BSE) as of 23-Dec-2015 IST. Roselabs Ltd has given a return of -37.42% in the last 1 years.
What is the current PB & PE ratio of Roselabs Ltd?
Since, TTM earnings of Roselabs Ltd is negative, P/E ratio is not available.
The P/B ratio of Roselabs Ltd is 0.79 times as on 23-Dec-2015, a 81 discount to its peers’ median range of 4.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2015 |
0.00 |
1.04 |
2014 |
0.00 |
1.15 |
2013 |
0.00 |
0.00 |
2012 |
0.00 |
0.00 |
2011 |
0.00 |
0.00 |
What is the 52 Week High and Low of Roselabs Ltd?
The 52-week high and low of Roselabs Ltd are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Roselabs Ltd?
Roselabs Ltd has a market capitalisation of ₹ 8 Cr as on 23-Dec-2015. As per SEBI classification, it is a company.
Should I invest in Roselabs Ltd?
Before investing in Roselabs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.